CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T(CAR-T)细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:OMIP-117: 40-Parameter/37-Color Spectral Cytometry Panel for Robust Immunoprofiling of Human Lymphoid Subsets in Cancer Patients.
OMIP-117: 40-Parameter/37-Color Spectral Cytometry Panel for Robust Immunoprofiling of Human Lymphoid Subsets in Cancer Patients.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
分析癌症患者的免疫细胞区室对于预测治疗疗效和复发至关重要。我们介绍一种稳健的光谱流式检测面板,包含40个参数、37个通道,用于分析人类淋巴细胞亚群和CAR-T 细胞扩增,并可通过检测免疫检查点和活化受体评估癌症患者的耗竭状态。该面板针对5激光Cytek Aurora平台开发,优化荧光染料选择,并将三对互斥标志物分配至同一荧光参数以简化设置、确保数据稳健;设计中采取保守方案,将相似性指数控制在0.85以下,但在遵循最佳实践时,更高重叠度也可获得高质量数据。该面板既可采用传统门控策略详细分析定义明确的淋巴细胞亚群,也可通过基于无监督算法的分析检测表达模式多变的非常规亚群。研究者通过模拟多发性骨髓瘤从癌前病变进展至高度侵袭阶段的数据集,展示了该面板的有效性。
The analysis of immune cell compartments in cancer patients is crucial to predict treatment efficacy and relapse.
We introduce a robust 40-parameter, 37-channel spectral cytometry panel designed to profile human lymphoid subsets and CAR-T cell expansion, with the capability to assess exhaustion status by profiling immune checkpoints and activating receptors in cancer patients. Developed for the 5-laser Cytek Aurora, the panel optimizes fluorophore selection and uses three pairs of mutually exclusive markers assigned to a single fluorescent parameter to simplify setup and ensure robust data, adopting a conservative design choice to keep similarity indices below 0.
85; though higher overlaps can still yield high-quality data when best practices are applied. The panel enables detailed analysis of well-defined lymphoid subsets using a conventional gating strategy, as well as detection of unconventional subsets with variable expression patterns by unsupervised algorithm-based analysis. The effectiveness of the panel is demonstrated through a dataset simulating the progression of multiple myeloma, from pre-malignant disease to a highly aggressive stage.
MEMBER ACCOUNT
登录成功会直接打开下一页。